Overview

Optimisation of Hydromorphone - Naloxone Ratio for the Treatment of Pain

Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish an optimal hydromorphone - naloxone ratio with an improved bowel function for constipated pain patients.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Mundipharma Research GmbH & Co KG
Treatments:
Hydromorphone
Naloxone